Medical Mishaps May Change Hospital Inspections
A recent NPR article explores proposed regulations that would entail private health care accreditors making health facility inspections public. The intention of the proposed regulations
A recent NPR article explores proposed regulations that would entail private health care accreditors making health facility inspections public. The intention of the proposed regulations
The EPA has shot down a proposed ban on the pesticide called chlorpyrifos, citing uncertainties over the chemical’s alleged safety risks. Environmental groups argue that
The MIT Technology Review reports on a health monitoring watch released by Verily,a health-based subsidiary of Google. The “Study Watch” is designed exclusively for applications
Staying awake while in surgery is becoming easier and more common. Some doctors believe this can lead to a better overall patient experience. Listen to

Many people view playing video games as “wasted time” and as a mere form of entertainment. Games also are often criticized regarding violence and explicit
In his TED Talk, Moshe Szyf explains recent advances in his field of epigenetics, which studies how certain genes in DNA are activated based on
The National Institute of Allergy and Infectious Diseases (NIAID), a part of the National Institutes of Health (NIH), is beginning the second phase of their
Last year, the Philadelphia city council voted to impose a tax on sweetened drinks. Advocates for the American Beverage Association and the Pennsylvania Food Merchants Association

This article was originally published on April 9, 2017 in The Hill. Lost in all the chaos surrounding the failed attempt to repeal the Affordable

According to sources familiar with the decision, Panera Bread Co. is considering a possible sale after receiving interest from at least one buyer. Panera operates
Spring has officially arrived, and everyone is starting to spend more time outdoors, which means increased sun exposure and allergies. See how much you know

The Food and Drug Administration (FDA) has approved Genentech’s new drug Ocrevus, which is the first approved treatment available for primary progressive multiple sclerosis (MS).